Results 161 to 170 of about 13,922 (281)

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

open access: yesAddiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski   +2 more
wiley   +1 more source

Front Matter [PDF]

open access: yes, 2019
Cruz, Maria, Francis, Taylor-Dawn
core   +1 more source

Autosomal Dominant Hyper‐IgE Syndrome Patients Retain IL10‐Producing preTh17‐Cells That Are Activated by Opportunistic Pathogens and Support IgE Production

open access: yesAllergy, EarlyView.
IL‐10 producing CCR6+Th‐cells are central memory T‐cells that express ROR‐γt and differentiate to Th17‐cells via an autocrine loop of STAT3‐activating cytokines (preTh17). STAT3‐deficient AD‐HIES patients lack Th17‐ and Tfh17‐cells but retain preTh17‐ and Th1/17‐cells.
Giorgia Moschetti   +18 more
wiley   +1 more source

Te Huarahi Roa—The Long Road

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Māori are significantly underrepresented within the surgical health workforce in Aotearoa, perpetuating longstanding inequities in access, experiences and outcomes. Little is known about the experiences of Māori across the continuum from medical school to consultancy.
Nasya Thompson, Ruth Herd, Jonathan Koea
wiley   +1 more source

Surgeon's imposter syndrome: a systematic review. [PDF]

open access: yesLangenbecks Arch Surg
El Boghdady M, Ewalds-Kvist B.
europepmc   +1 more source

Home - About - Disclaimer - Privacy